Pulmonary Vascular Disease Due to Plasma Cell Dyscrasia
Pulmonary hypertension (PH) has been described in myeloproliferative disorders; monoclonal plasma cell disorder such as polyneuropathy, organomegaly, endocrinopathy, monoclonal gammopathy, and skin changes syndrome; and plasma cell dyscrasias such as multiple myeloma and amyloidosis. We describe 4 c...
Main Authors: | Indranee Rajapreyar, MD, Joanna Joly, MD, Jose Tallaj, MD, Salpy V. Pamboukian, MD, Ayman Haj Assad, MD, Carrie Lenneman, MD, Silvio Litovsky, MD, Arka Chatterjee, MD, Charles Hoopes, MD, Andrew Lenneman, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-02-01
|
Series: | Mayo Clinic Proceedings: Innovations, Quality & Outcomes |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2542454820301879 |
Similar Items
-
Persistent mitral regurgitation after left ventricular assist device: a clinical conundrum
by: Jose B. Cruz Rodriguez, et al.
Published: (2021-04-01) -
A Case of Heart Failure in a Patient With Systemic Lupus Erythematosus
by: Heriberto Matos Santana, MD, et al.
Published: (2020-03-01) -
A case of plasma cell dyscrasia presenting as nonscarring alopecia
by: Benjamin Nia, MD, et al.
Published: (2021-09-01) -
Recalcitrant cutaneous pyoderma gangrenosum with pulmonary involvement resolved with treatment of underlying plasma cell dyscrasia
by: Tyler A. Hooton, MD, et al.
Published: (2021-03-01) -
Evolution of Immune Checkpoint Blockade–Induced Myocarditis Over 2 Years
by: Timothy G. Norwood, et al.
Published: (2020-02-01)